Deutsche Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Deutsche Bank's BMY Position: Q1 2026 in Review
Deutsche Bank increased its Bristol-Myers Squibb (BMY) stake by 2.7% in Q1 2026, buying an estimated $14M and bringing the position to 9,036,485 shares worth $548M. The position accounts for 0.18% of the portfolio, ranked #124.
Deutsche Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.39B in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Deutsche Bank held 9,036,485 shares of Bristol-Myers Squibb worth $548M as of Q1 2026.
- Deutsche Bank bought 240,752 Bristol-Myers Squibb shares in Q1 2026, an estimated $14M.
- Bristol-Myers Squibb made up 0.18% of Deutsche Bank's portfolio in Q1 2026, its #124 holding.
- Deutsche Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Bristol-Myers Squibb position peaked at $1.39B in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.